HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Memory B cell repertoire for recognition of evolving SARS-CoV-2 spike.

Abstract
Memory B cell reserves can generate protective antibodies against repeated SARS-CoV-2 infections, but with unknown reach from original infection to antigenically drifted variants. We charted memory B cell receptor-encoded antibodies from 19 COVID-19 convalescent subjects against SARS-CoV-2 spike (S) and found seven major antibody competition groups against epitopes recurrently targeted across individuals. Inclusion of published and newly determined structures of antibody-S complexes identified corresponding epitopic regions. Group assignment correlated with cross-CoV-reactivity breadth, neutralization potency, and convergent antibody signatures. Although emerging SARS-CoV-2 variants of concern escaped binding by many members of the groups associated with the most potent neutralizing activity, some antibodies in each of those groups retained affinity-suggesting that otherwise redundant components of a primary immune response are important for durable protection from evolving pathogens. Our results furnish a global atlas of S-specific memory B cell repertoires and illustrate properties driving viral escape and conferring robustness against emerging variants.
AuthorsPei Tong, Avneesh Gautam, Ian W Windsor, Meghan Travers, Yuezhou Chen, Nicholas Garcia, Noah B Whiteman, Lindsay G A McKay, Nadia Storm, Lauren E Malsick, Anna N Honko, Felipe J N Lelis, Shaghayegh Habibi, Simon Jenni, Yongfei Cai, Linda J Rennick, W Paul Duprex, Kevin R McCarthy, Christy L Lavine, Teng Zuo, Junrui Lin, Adam Zuiani, Jared Feldman, Elizabeth A MacDonald, Blake M Hauser, Anthony Griffths, Michael S Seaman, Aaron G Schmidt, Bing Chen, Donna Neuberg, Goran Bajic, Stephen C Harrison, Duane R Wesemann
JournalCell (Cell) Vol. 184 Issue 19 Pg. 4969-4980.e15 (09 16 2021) ISSN: 1097-4172 [Electronic] United States
PMID34332650 (Publication Type: Journal Article)
CopyrightCopyright © 2021 Elsevier Inc. All rights reserved.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: